Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients (2016)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; NASSUR, MARIA EUGENIA QUEIROZ - FFCLRP
- Unidades: FMRP; FFCLRP
- DOI: 10.1093/jat/bkv107
- Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA; ESPECTROMETRIA DE MASSAS; ANTIPSICÓTICOS; ANTIDEPRESSIVOS; ANTICONVULSIVANTES; ANSIOLÍTICOS; PLASMA (AMOSTRA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Analytical Toxicology
- ISSN: 0146-4760
- Volume/Número/Paginação/Ano: v. 40, n. 1, p. 28-36, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DOMINGUES, Diego Soares et al. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients. Journal of Analytical Toxicology, v. 40, n. 1, p. 28-36, 2016Tradução . . Disponível em: https://doi.org/10.1093/jat/bkv107. Acesso em: 27 dez. 2025. -
APA
Domingues, D. S., Pinto, M. A. L., Souza, I. D. de, Hallak, J. E. C., Crippa, J. A. de S., & Queiroz, M. E. C. (2016). Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients. Journal of Analytical Toxicology, 40( 1), 28-36. doi:10.1093/jat/bkv107 -
NLM
Domingues DS, Pinto MAL, Souza ID de, Hallak JEC, Crippa JA de S, Queiroz MEC. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients [Internet]. Journal of Analytical Toxicology. 2016 ; 40( 1): 28-36.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1093/jat/bkv107 -
Vancouver
Domingues DS, Pinto MAL, Souza ID de, Hallak JEC, Crippa JA de S, Queiroz MEC. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients [Internet]. Journal of Analytical Toxicology. 2016 ; 40( 1): 28-36.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1093/jat/bkv107 - The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
- Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
- Postural balance in patients with social anxiety disorder
- Short-term treatment of Catatonia with amantadine in schizophrenia and schizoaffective disorder. [Carta]
- New treatment options for panic disorder: clinical trials from 2000 to 2010
- Public speaking in social phobia: a pilot study of self-ratings and observers' ratings of social skills
- Arterial spin labeling in patients with schizophrenia: a systematic review
- Randomized, open naturalistic, acute treatment of panic Disorder with clonazepam or paroxetine [carta]
- Antipsicóticos e alterações metabólicas
- Default mode network changes induced by Ayahuasca
Informações sobre o DOI: 10.1093/jat/bkv107 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
